<DOC>
	<DOCNO>NCT01186562</DOCNO>
	<brief_summary>The purpose study test effect sitagliptin need insulin ( hormone lower blood sugar ) patient receive pancreatectomy islet autotransplant chronic pancreatitis .</brief_summary>
	<brief_title>Sitagliptin Therapy Improve Outcomes After Islet Autotransplant</brief_title>
	<detailed_description>At current time , one-third patient insulin independent ( need take insulin ) autotransplant , two-thirds still need insulin . Sitagliptin work increase amount hormone call glucagon-like peptide 1 , GLP-1 , body increase amount insulin make beta cell ( insulin produce cell islet ) . GLP-1 might also help protect beta cell die stressful condition increase production new beta cell . The primary goal study see take sitagliptin one year islet autotransplant increase number patient achieve maintain insulin independence . Other goal study see sitagliptin reduces amount insulin injection need helps islet make insulin .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Age ≥18 year Scheduled total pancreatectomy IAT UM Preexisting diabetes mellitus hyperglycemia fast glucose ≥115 mg/dl Medical condition , opinion investigator , might impact islet function ( e.g asthma inflammatory disease require chronic systemic corticosteroid ) Significant renal disease : serum creatinine level &gt; 3.0 mg/dL men &gt; 2.5 mg/dL woman , endstage renal disease require hemodialysis peritoneal dialysis . For female subject , plan become pregnant unwillingness practice birth control 18 month . Islet yield &lt; 1,000 IE/kg body weight ( exclusion treatment drug/placebo )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pancreatitis</keyword>
	<keyword>Pancreatectomy</keyword>
	<keyword>Islet autotransplant</keyword>
	<keyword>Sitagliptin</keyword>
	<keyword>Diabetes</keyword>
</DOC>